ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 43 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,392 | +82.1% | 96,824 | +455.8% | 0.00% | – |
| Q2 2022 | $9,000 | -64.0% | 17,422 | -58.2% | 0.00% | – |
| Q4 2021 | $25,000 | -50.0% | 41,716 | -18.9% | 0.00% | – |
| Q3 2021 | $50,000 | +284.6% | 51,452 | +351.3% | 0.00% | – |
| Q2 2021 | $13,000 | -58.1% | 11,400 | -64.2% | 0.00% | – |
| Q1 2021 | $31,000 | +93.8% | 31,846 | +57.0% | 0.00% | – |
| Q3 2020 | $16,000 | -20.0% | 20,279 | -45.3% | 0.00% | – |
| Q2 2020 | $20,000 | +66.7% | 37,080 | +118.3% | 0.00% | – |
| Q4 2019 | $12,000 | -61.3% | 16,989 | +23.6% | 0.00% | – |
| Q4 2018 | $31,000 | -38.0% | 13,740 | +28.6% | 0.00% | -100.0% |
| Q3 2014 | $50,000 | -37.5% | 10,681 | -35.8% | 0.00% | 0.0% |
| Q2 2014 | $80,000 | -22.3% | 16,646 | +2.8% | 0.00% | 0.0% |
| Q1 2014 | $103,000 | – | 16,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |